ME/CFS brain fog linked to impaired glymphatic waste clearance system

Researchers at the National Centre for Neuroimmunology and Emerging Diseases (NCNED) at Griffith University have identified a link between the cognitive impairment known as brain fog and the impairment of the brain's waste clearance system, the glymphatic system. Findings published in the journal Frontiers in Neuroscience mark the first instance in which MRI technology has been utilized to observe compromised glymphatic function in patients diagnosed with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

The glymphatic system functions as a drainage network, flushing out metabolic waste products and toxins from the central nervous system. This process is primarily active during sleep. When this drainage system fails to function efficiently, metabolic byproducts — such as lactate, glutamate, and protein aggregates — accumulate. Researchers associate this buildup with the neuroinflammation observed in clinical settings, providing a possible mechanistic explanation for the cognitive symptoms that define the disease.

Media additions

Dr. Kiran Thapaliya, the study’s lead author, noted that the results offer a mechanism for inflammatory changes previously documented by both Australian and international research teams. The study also established a correlation between poor sleep quality and reduced waste clearance, further supporting the long-standing observation that sleep disruptions are central to the health of patients with ME/CFS. According to Professor Sonya Marshall-Gradisnik, Director of NCNED, the findings underscore the importance of sleep in maintaining brain health and offer a potential pathway toward the development of non-invasive diagnostic procedures.

Biological Mechanisms and Systemic Impacts

The glymphatic system relies on the polarization of aquaporin-4 (AQP4) water channels. These proteins are located on the end-feet of astrocytes, which are the cells responsible for maintaining the brain's chemical environment. When AQP4 channels are dysfunctional or displaced, the movement of cerebrospinal fluid is restricted, leading to the accumulation of toxic substances. This disruption is theorized to trigger a cascade of systemic issues, including blood-brain barrier dysfunction, chronic neuroinflammation, sleep instability, dysautonomia, and potential viral reactivation.

The research aligns with the current medical understanding of ME/CFS as a complex neuroimmune disorder. While the World Health Organization has classified ME/CFS as a neurological disease since 1969, the medical community continues to face significant diagnostic challenges. Estimates suggest that up to 90% of affected individuals remain undiagnosed.

Broader Context and Scientific Debate

Historical reports from the 1930s described post-viral illnesses with symptoms similar to modern ME/CFS. Researchers now examine various biological abnormalities, including mitochondrial dysfunction, oxidative stress, and the presence of autoantibodies, to determine how they intersect with glymphatic impairment. Evidence indicates that up to 49% of patients with Long COVID meet the diagnostic criteria for ME/CFS, prompting further investigations into whether glymphatic system dysregulation serves as a common denominator between these conditions.

Future Clinical Objectives

As the scientific community evaluates this model, researchers have identified several priority areas for clinical investigation:

The integration of these findings into clinical practice remains a goal for future research. By targeting the mechanisms that cause waste accumulation, scientists hope to develop novel treatments that might alleviate the debilitating cognitive symptoms and physical crashes that characterize ME/CFS.